SANA BIOTECHNOLOGY INC. - COMMON STOCK

Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute

12 5 2022 17:40:02 提供 Nasdaq GlobeNewswire

Sana Biotechnology Reports First Quarter 2022 Financial Results and Business Updates

10 5 2022 16:05:01 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present at the BofA Securities 2022 Healthcare Conference

04 5 2022 16:05:01 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present Data from Multiple Preclinical Studies at the American Society of Gene and Cell Therapy 25th Annual Meeting

02 5 2022 16:35:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

16 3 2022 08:30:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 32nd Annual Oppenheimer Healthcare Conference

09 3 2022 16:05:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting

08 3 2022 16:35:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct

11 1 2022 06:00:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

10 1 2022 16:30:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 1 2022 16:05:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs

12 12 2021 09:05:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates

08 11 2021 16:05:02 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting

04 11 2021 09:07:03 提供 Nasdaq GlobeNewswire

Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs

19 10 2021 09:00:01 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

07 9 2021 16:05:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates

04 8 2021 16:05:04 提供 Nasdaq GlobeNewswire

Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

14 7 2021 16:10:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

26 6 2021 10:42:38 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

14 6 2021 09:15:00 提供 Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

02 6 2021 16:05:00 提供 Nasdaq GlobeNewswire